1. Heller, Scott A, Shih, Renata, Kalra, Raghav, Kang, Peter B. 2019. Emery-Dreifuss muscular dystrophy. In Muscle & nerve, 61, 436-448. doi:10.1002/mus.26782. https://pubmed.ncbi.nlm.nih.gov/31840275/
2. Skoulidis, Ferdinandos, Heymach, John V. 2019. Co-occurring genomic alterations in non-small-cell lung cancer biology and therapy. In Nature reviews. Cancer, 19, 495-509. doi:10.1038/s41568-019-0179-8. https://pubmed.ncbi.nlm.nih.gov/31406302/
3. Robichaux, Jacqulyne P, Le, Xiuning, Vijayan, R S K, Gray, Jhanelle E, Heymach, John V. 2021. Structure-based classification predicts drug response in EGFR-mutant NSCLC. In Nature, 597, 732-737. doi:10.1038/s41586-021-03898-1. https://pubmed.ncbi.nlm.nih.gov/34526717/
4. Cleary, James M, Aguirre, Andrew J, Shapiro, Geoffrey I, D'Andrea, Alan D. 2020. Biomarker-Guided Development of DNA Repair Inhibitors. In Molecular cell, 78, 1070-1085. doi:10.1016/j.molcel.2020.04.035. https://pubmed.ncbi.nlm.nih.gov/32459988/
5. Vázquez-García, Ignacio, Uhlitz, Florian, Ceglia, Nicholas, Zamarin, Dmitriy, Shah, Sohrab P. 2022. Ovarian cancer mutational processes drive site-specific immune evasion. In Nature, 612, 778-786. doi:10.1038/s41586-022-05496-1. https://pubmed.ncbi.nlm.nih.gov/36517593/